Background: Meningioma is one of the most common primary brain neoplasms with poor outcomes. The present study was aimed to determine clinical and surgical characteristics of intracranial meningiomas associated with tumor recurrence and complications. Methods: A total of 138 patients undergoing surgical resection of intracranial meningiomas between Jan 2003 and Dec 2014 were included and followed for the period of at least 12 months. The demographic and clinical characteristics possibly associated with tumor recurrence were assessed, including age, gender, clinical symptoms, pathology data, tumor parameters, preoperative and postoperative Karnofsky Performance Scale (KPS), complications and recurrence rate. Results: One hundred and twenty one lesions were benign (classified as Grade I) and 17 were atypical/ malignant (classified as Grade II/III). The patients were of a mean age of 60.5 years and a mean follow-up duration of 36.8 months (range, 16.3e62.9 months). The 1, 3, 5-year recurrence/tumor enlargement rates were 3.4%, 7.2%, and 15.7%, respectively. In multivariate analysis, symptoms of disturbance of consciousness and palpable cranial mass were associated with increased recurrence/tumor enlargement. In addition, patients with Simpson grade IV were more likely to have recurrence/tumor enlargement. Conclusion: The pattern of intracranial meningioma in this series is typical to other studies. Presenting symptoms is suggested to be predictive of recurrence.
Introduction
Meningioma is one of the most common primary brain neoplasms, accounting for approximately 30% of tumors in central nerve system. It arises from the cells covering arachnoid layer of brain or spinal cord, characterized by a homogeneous enhancement of mass with a dural tail on magnetic resonance imaging. Based on World Health Organization (WHO) classification of tumor, meningiomas are graded into three categories on the basis of histological features 1 . Approximately 90% of meningiomas are benign (Grade I) and have slow growth, with incidence increasing with age 2 . However, some meningiomas are considered as atypical (Grade II) and malignant (Grade III), representing a major challenge to neurosurgeons.
Surgical resection is considered as an optimal therapeutic modality for symptomatic meningioma with the aim of complete removal of tumor. Although patients with benign meningiomas have high survival rates, patients with symptomatic meningiomas suffer from postoperative complications and long-term disability 2e4 . Recurrences after extent of surgical resection are reported more frequently in patients with higher-grade tumors 4 . In cases of recurrence or incompletely removed tumors, radiotherapy and radiosurgery are recommended. Nevertheless, the factors associated with recurrent meningiomas remain sketchy.
In the present study, we determined the recurrence rate and predictive factors for recurrence of meningiomas. We reviewed and presented the results of the clinical outcomes of the patients treated conservatively in our department over a period of 12-year. We compared the characteristics of intracranial meningiomas in our series with the pattern reported in the literatures.
Materials and methods

Patients
Patients undergoing surgery for meningioma at Mackey memorial hospital between Jan 2003 and Dec 2014 were included. The study protocol was reviewed and approved by institutional review board (IRB approval number: 15MMHIS077). All patients were diagnosed with meningioma using magnetic resonance imaging (MRI), radiological modalities and computed tomographic (CT) scanning incorporating with the results of histopathological examination. Exclusion criteria were previous radiation therapy, recurrence of meningioma and presence of other malignancy.
Clinical parameters and outcome assessment
The demographic and clinical characteristics possibly associated with tumor recurrence were assessed, including age, gender, clinical symptoms, pathology data, tumor parameters, preoperative and postoperative Karnofsky Performance Scale (KPS), post-surgery complications and recurrence rate 5 . Focal neurologica deficit were defined as impaired function of cranial nerve, including facial palsy, hemifacial spasm, anosmia, hearing loss and ptosis. Tumor locations were classified into following sublocations based on radiologic studies using CT or MRI, which included parasagittal, convexity, sphenoid ridge, olfactory groove, parafalcine, posterior fossa, middle fossa, cerebellopontine angle, tuberculum sella, planum sphenoidale, tentorial and intraventricular. T1-weighted MRI and CT scanning were employed to determine the maximal size of the tumor. The extent of surgical removal of tumor was classified using Simpson's scale into 5 grades 6 . All meningiomas were graded according to the WHO classification system. KPS was utilized to evaluate the pre-and post-operative clinical status. Patients with KPS above 70 were considered as in good performance status.
Statistical analysis
The cumulative recurrence and tumor enlargement rate were performed using the KaplaneMeier estimates. The factors associated with recurrence/tumor enlargement were examined using the Cox proportional hazard model. When there were two or more factors with p-value less than 0.2 in the univariable Cox proportional hazard models, the factors would be included into the multivariable model by using backward conditional method. The continuous data between two age groups were tested with the independent two samples t-test and the ManneWhiney U test, respectively for normal-distributed and non-normal distributed continuous data. The Fisher's exact test was employed to test with the associations of age group versus categorical data. A p-value less than 0.05 was considered as statistical significance. Statistical analyses were performed using the software IBM SPSS Statistics 22.0 (IBM Corporation, Armonk, New York).
Results
A total of 138 patients with intracranial meningioma were enrolled in the study, including 95 females (68.8%) and 43 males (31.2%), with a mean age of 60.5 years (SD ¼ 12.2 years). 36 (26.1%) patients had a preoperative embolization before operation. The most frequent presenting symptom of these patients was motor deficit (n ¼ 45, 32.6%), followed by headache (n ¼ 38, 27.5%) and dizziness (n ¼ 30, 21.7%) ( Table 1) . Of 138 patients, 60 had tumors located in convexity (43.5%), 19 patients had parasagittal meningioma (13.8%), and 13 patients were with the tumors located in sphenoid ridge (9.4%). The pathology results showed that 87.7% (n ¼ 121) of meningiomas were benign (Grade I). 8 patients who had focal neurologica deficit were defined as impaired function of cranial nerve, including 2 facial palsy, 1 hemifacial spasm, 2 anosmia, 2 hearing loss and 1 ptosis. Detailed clinical demographics and characteristics of the patients were summarized and presented in Table 1 .
The median hospitalized duration after operation was 12 days (IQR in 10e18 days), and 16 patients treated with radiotherapy after operation (11.6%). The majority of post-operative complications included 16 intracerebral hematoma (11.6%) and 10 pneumonia (7.2%). At the time of discharge, 88 (63.8%) of the patients had Karnofsky scores over 70 (undependent). In addition, ninety-nine patients (71.7%) had improved outcome but 17 (12.3%) had deteriorated outcome (Table 2) .
We examined the recurrence/tumor enlargement rate of each time point. As shown Fig. 1 , the 1, 3, 5-year recurrence/tumor enlargement rates were 3.4%, 7.2%, and 15.7%, respectively. (Table 3) . We next stratified the population by age over 65 years, resulting in 85 (61.6%) aged < 65 years and 53 (38.4%) aged 65 years. The results showed a significantly high incidence of headache in the patients aged <65 years compared with that of the patients aged 65 years (36.5% vs. 13.2%, p ¼ 0.003). Meningioma patients aged 65 years were more likely to have disturbance of consciousness (20.8% vs. 4.7%, p ¼ 0.005). Our data showed that preoperative embolization before operation was more frequently indicated to younger patients with meningiomas (32.9% vs. 15.1%, p ¼ 0.028). Inhospital length of stay was significantly longer in patients aged 65 years than the younger ones (medians of 14 vs. 11 days, p < 0.001) ( Table 4) . With fixing the conditions of preoperative embolization and Karnofsky scoring before operation, the association between age and Karnofsky scoring on discharge remained statistically significant (p ¼ 0.013), and each 10 years increasing of age would resulted in 3.74 decreasing of Karnofsky scoring on discharge.
Discussion
Meningioma is a common brain tumor type occurring at all ages with a peak incidence in sixth and seven decade of life. Our study showed a mean age of 60.5 years at diagnosis for the meningioma patients, which is in agreement with other Asian studies 7e10 . Mean age at diagnosis of meningiomas has been suggested to be less in African-origin population ranging from 39.9 to 45.7 than Caucasian ranging from 57 to 59.1 11e15 . In addition to age distribution, increasing evidence has highlighted a sex disparity in meningiomas with a ratio of males to females ranging from 1:1.1 to 1:3.8. It has been reported that the female preponderance in the African-origin population is less than that in other ethnic groups 16 . Our results
showing a male-to-female ratio of 1:2.2 were in agreement with previous studies in Caucasian populations 17, 18 . Interestingly, a recent population-based study has reported an absence of female predominance among patients with intracranial meningiomas undergoing surgery 18 . The differences are possibly explained by different genetic, environmental or other factors. We noted a similar sex difference stratified by age <65 and age 65, whereas there was a higher male-to-female ration in patients age <65 (1:2.0).
Location of the meningioma is suggested to be a determining factor in surgical resectability and prognosis. Meningiomas are frequently found in the convexity, parasagittal, and falx regions 17, 19 .
Less common locations for meningiomas include olfactory groove, Fig. 1 . The cumulative recurrence/tumor enlargement rate by the KaplaneMeier estimates. Data are presented by number with percentage except for z the duration of hospitalization after operation is presented by median with inter-quartile range.
sphenoid wing and posterior fossa 17, 20 . A recent study conducted in Nigeria reported a different anatomical distribution of meningiomas 16 . The common locations of intracranial meningiomas have been suggested to vary among reports 21, 22 . In our study, the common anatomical location of meningioma was cerebral convexity followed by parasagittal region. This finding is in agreement with previous studies that meningiomas in adults are found commonly located in cerebral convexity. We also found tumors located within tentorium (0.7%) and ventricle (0.7%), which are considered to be more common in children 23, 24 . Most of intracranial meningiomas are histologically graded as benign, whereas 5e10% of meningiomas exhibit aggressive behavior as high-grade (WHO grade II/III) 2, 25 . In our series, the distribution of tumor types was similar to other studies, showing a predominance of benign meningiomas (87.7%). Despite of being a slow-growing histologically benign tumor, recurrence rates of meningiomas after surgery with unfavorable clinical course remain high. Atypical and malignant meningiomas has been reported to exhibit higher recurrence rate compared with that of benign tumors (WHO grade I) 26, 27 . However, a significant number of meningioma relapses occur among benign meningiomas 28 . In addition to WHO grading, Simpson grading system describing the completeness of resection is suggested as a predictor of meningioma progression and recurrence. In our series, the overall recurrence rate was 24.1%. Univariable analysis revealed that Simpson grade IV was significantly associated with recurrence risk compared with the other grades. The finding is similar to previous studies focusing on the relationship of Simpson grade and meningioma control 29e31
. Several factors have been associated with high risk for meningioma recurrence, including peritumoral brain edema, cellular pleomorphism, neovascularization, presence of macronuclei and brain invasion 32e35 . In the present study, we found that meningioma patients with presenting symptoms, namely disturbance of consciousness and palpable cranial mass had an increased tendency to recur after surgery. It is suggested that presenting symptoms upon diagnosis may stand as predictor for recurrence after surgery incorporating with other tools. However, further study in large population is required to confirm this finding. In this series, tumor size and location were found to have no influence on meningioma relapse. Moreover, association of patient gender and age with recurrence was insignificant. The incidence rate of meningiomas increases significantly in people over 65 36 . An age of >60 years at diagnosis has been reported to be a predictor of worse outcomes among advanced meningioma patients. In our series, there were postoperative complications in 60 of 138 patients (43.3%) with a majority of complications related to surgery, including hematoma, infections, seizure and cranial nerve injury. This finding is agreed with a previous series showing a morbidity rate of 37% 37 . However, the morbidity rates were comparable between two groups, aged <65 years and aged 65 years. A significant difference was observed in the duration of hospitalization between two age groups. It is indicated that age over 65 serves as a predictor for poor outcome.
This study had several limitations. Firstly, the nature of retrospective study design is likely to be bias. Second of all, a mean follow-up duration of 36.8 months may lead to underestimating late recurrences that may occur in 4 years after surgery. A final limitation is that of the small number of trials as well as heterogeneity of treatments. In this series, the tumor location, histological characteristic and grades as well as age and sex distribution were similar and comparable to other studies. The results suggest that presenting symptom may represent a predictive factor for recurrence. A multicenter study is required to elucidate the postoperative morbidity of intracranial meningiomas.
